ID   PICK1_PONAB             Reviewed;         415 AA.
AC   Q5REH1;
DT   26-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   21-DEC-2004, sequence version 1.
DT   07-APR-2021, entry version 80.
DE   RecName: Full=PRKCA-binding protein;
DE   AltName: Full=Protein interacting with C kinase 1;
DE   AltName: Full=Protein kinase C-alpha-binding protein;
GN   Name=PICK1; Synonyms=PRKCABP;
OS   Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Pongo.
OX   NCBI_TaxID=9601;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver;
RG   The German cDNA consortium;
RL   Submitted (NOV-2004) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Probable adapter protein that bind to and organize the
CC       subcellular localization of a variety of membrane proteins containing
CC       some PDZ recognition sequence. Involved in the clustering of various
CC       receptors, possibly by acting at the receptor internalization level.
CC       Plays a role in synaptic plasticity by regulating the trafficking and
CC       internalization of AMPA receptors. May be regulated upon PRKCA
CC       activation. May regulate ASIC1/ASIC3 channel. Regulates actin
CC       polymerization by inhibiting the actin-nucleating activity of the
CC       Arp2/3 complex; the function is competetive with nucleation promoting
CC       factors and is linked to neuronal morphology regulation and AMPA
CC       receptor (AMPAR) endocytosis. Via interaction with the Arp2/3 complex
CC       involved in regulation of synaptic plasicity of excitatory synapses and
CC       required for spine shrinkage during long-term depression (LTD).
CC       Involved in regulation of astrocyte morphology, antagonistic to Arp2/3
CC       complex activator WASL/N-WASP function (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Monomer and homodimer. Interacts with CXADR. Interacts
CC       presynaptically with the glutamate receptors GRIA2, GRIA3, GRIK3,
CC       isoform 3 of GRIA4, isoform A of GRM4, GRM7 and GRM8; with NAPA and
CC       NAPB; and with BTG2. The interaction with NAPA and NAPB disrupts the
CC       interaction with GRIA2, conducting to the internalization of GRIA2.
CC       Interacts with PRKCA; with the amine transporters SLC6A2 and SLC6A3;
CC       with the channels ASIC1 and ASIC2; with the GTP-binding proteins ARF1
CC       and ARF3; with the ephrin receptor tyrosine kinases EPHA7, EPHB1 and
CC       EPHB2; with ERBB2 and through its PDZ domain with the C-terminal tail
CC       of PRLHR. Interacts with UNC5A. Interacts (via AH domain) with
CC       NCS1/FREQ; in a calcium-dependent manner. Interacts with F-actin and
CC       associates with the ARP2/3 complex. Interacts (via PDZ domain) with
CC       ARF1 (activated); the interaction blocks Arp2/3 complex inhibition (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, perinuclear region {ECO:0000250}.
CC       Membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}.
CC       Membrane {ECO:0000250}; Lipid-anchor {ECO:0000250}. Cell junction,
CC       synapse, postsynaptic density {ECO:0000250}. Cell junction, synapse,
CC       synaptosome {ECO:0000250}. Cytoplasm, cytoskeleton {ECO:0000250}.
CC       Note=Also membrane-associated, present at excitatory synapses.
CC       {ECO:0000250}.
CC   -!- DOMAIN: The AH domain mediates binding to F-actin. {ECO:0000250}.
CC   -!- DOMAIN: The unoccupied PDZ domain is probably involved in allosteric
CC       modulation by forming an intramolecular bridge with the AH domain
CC       leading to a 'closed' formation. Binding of a PDZ ligand, such as
CC       GRIA2, allows enhanced interactions with F-actin and the Arp2/3 complex
CC       thus enhanced inhibition of actin polymerization (By similarity).
CC       {ECO:0000250}.
CC   -!- PTM: Phosphorylation at Thr-82 appears to inhibit the interaction with
CC       AMPA receptors. {ECO:0000250}.
CC   -!- PTM: Palmitoylation on Cys-413 is essential for long-term synaptic
CC       depression (LTD). {ECO:0000250}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CR857558; CAH89836.1; -; mRNA.
DR   RefSeq; NP_001124851.1; NM_001131379.1.
DR   SMR; Q5REH1; -.
DR   STRING; 9601.ENSPPYP00000013176; -.
DR   GeneID; 100171712; -.
DR   KEGG; pon:100171712; -.
DR   CTD; 9463; -.
DR   eggNOG; KOG3651; Eukaryota.
DR   InParanoid; Q5REH1; -.
DR   OMA; FTQISAH; -.
DR   OrthoDB; 545640at2759; -.
DR   Proteomes; UP000001595; Unplaced.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0043005; C:neuron projection; ISS:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0014069; C:postsynaptic density; IEA:UniProtKB-SubCell.
DR   GO; GO:0051015; F:actin filament binding; ISS:UniProtKB.
DR   GO; GO:0071933; F:Arp2/3 complex binding; ISS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0019904; F:protein domain specific binding; IEA:InterPro.
DR   GO; GO:0036294; P:cellular response to decreased oxygen levels; ISS:UniProtKB.
DR   GO; GO:0042149; P:cellular response to glucose starvation; ISS:UniProtKB.
DR   GO; GO:0097062; P:dendritic spine maintenance; ISS:UniProtKB.
DR   GO; GO:0097061; P:dendritic spine organization; ISS:UniProtKB.
DR   GO; GO:0021782; P:glial cell development; ISS:UniProtKB.
DR   GO; GO:0060292; P:long-term synaptic depression; ISS:UniProtKB.
DR   GO; GO:0034316; P:negative regulation of Arp2/3 complex-mediated actin nucleation; ISS:UniProtKB.
DR   GO; GO:0002092; P:positive regulation of receptor internalization; ISS:UniProtKB.
DR   CDD; cd07659; BAR_PICK1; 1.
DR   Gene3D; 1.20.1270.60; -; 1.
DR   Gene3D; 2.30.42.10; -; 1.
DR   InterPro; IPR027267; AH/BAR_dom_sf.
DR   InterPro; IPR010504; AH_dom.
DR   InterPro; IPR030798; Arfaptin_fam.
DR   InterPro; IPR001478; PDZ.
DR   InterPro; IPR036034; PDZ_sf.
DR   InterPro; IPR037959; PICK1_BAR.
DR   PANTHER; PTHR12141; PTHR12141; 1.
DR   Pfam; PF06456; Arfaptin; 1.
DR   Pfam; PF00595; PDZ; 1.
DR   SMART; SM01015; Arfaptin; 1.
DR   SMART; SM00228; PDZ; 1.
DR   SUPFAM; SSF103657; SSF103657; 1.
DR   SUPFAM; SSF50156; SSF50156; 1.
DR   PROSITE; PS50870; AH; 1.
DR   PROSITE; PS50106; PDZ; 1.
PE   2: Evidence at transcript level;
KW   Actin-binding; Calcium; Cell junction; Cytoplasm; Cytoskeleton;
KW   Lipoprotein; Membrane; Metal-binding; Palmitate; Phosphoprotein;
KW   Reference proteome; Synapse; Synaptosome; Zinc.
FT   CHAIN           1..415
FT                   /note="PRKCA-binding protein"
FT                   /id="PRO_0000318900"
FT   DOMAIN          22..105
FT                   /note="PDZ"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   DOMAIN          144..357
FT                   /note="AH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00294"
FT   COMPBIAS        382..388
FT                   /note="Poly-Glu"
FT   METAL           44
FT                   /note="Zinc"
FT                   /evidence="ECO:0000250"
FT   METAL           46
FT                   /note="Zinc"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         82
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NRD5"
FT   LIPID           413
FT                   /note="S-palmitoyl cysteine; by DHHC8"
FT                   /evidence="ECO:0000250"
SQ   SEQUENCE   415 AA;  46584 MW;  C569FD94A4E28B90 CRC64;
     MFADLDYDIE EDKLGIPTVP GKVTLQKDAQ NLIGISIGGG AQYCPCLYIV QVFDNTPAAL
     DGTVAAGDEI TGVNGRSIKG KTKVEVAKMI QEVKGEVTIH YNKLQADPKQ GMSLDIVLKK
     VKHRLVENMS SGTADALGLS RAILCNDGLV KRLEELERTA ELYKGMTEHT KNLLRAFYEL
     SQTHRAFGDV FSVIGVREPQ PAASEAFVKF ADAHRSIEKF GIRLLKTIKP MLTDLNTYLN
     KAIPDTRLTI KKYLDVKFEY LSYCLKVKEM DDEEYSCIAL GEPLYRVSTG NYEYRLILRC
     RQEARARFSQ MRKDVLEKME LLDQKHVQDI VFQLQRLVST MSKYYNDCYA VLRDADVFPI
     EVDLAHTTLA YGLNQEEFTD GEEEEEEEDT AAGEPARDTR GAAGPLDKGG SWCDS
//
